Condition
Solid Organ Transplant Rejection
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Unknown2
Completed1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06216015Not ApplicableCompletedPrimary
Exercise Training and Kidney Transplantation
NCT06997471Phase 1Not Yet Recruiting
Phase I Trial on the Safety of Delayed Infusion of a Naïve T Cell-Depleted Hematopoietic Graft With Memory T Cells in Solid Organ Transplant Recipients
NCT05215288UnknownPrimary
Expanded Access for Use of ExoFlo in Abdominal Solid Organ Transplant Patients
NCT04341103UnknownPrimary
AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience
Showing all 4 trials